Rocket Lab’s Archimedes vacuum engine aced a nearly 5.5-minute full-thrust test at NASA’s Stennis Space Center on July 13 — a critical milestone for the Neutron rocket’s second stage and a clear sign that the company’s engineering machine is humming. Yet the stock can’t seem to catch a bid. Shares slid 6.77% on Thursday to €62.00 after Piper Sandler kicked off coverage with a Neutral rating and an $83 price target, breaking a streak of 16 analysts who had all held bullish views.
The Piper Sandler call landed like a cold front on a market already unsettled by insider selling and an $8 billion acquisition. The $83 target offered little upside from the current level, and analysts noted that while Rocket Lab’s operational story remains strong — record first-quarter revenue of $200 million and a $2.2 billion backlog — the stock’s technical picture has darkened. After hitting a 52-week high of €133.80 in May, the shares have now given back more than half their value, with the 14-day relative strength index dropping to 31.4, deep into oversold territory.
The decline has brought the stock close to its 200-day moving average of €67.30, a level technicians view as a make-or-break support zone. Over the past month, the stock has tumbled 26.27%, and while the 12-month return still sits at a respectable 62.20%, the speed of the current pullback has rattled short-term investors. Trading volume on Wednesday came in at 15.2 million shares, roughly 38% below the daily average — a sign that many are waiting on the sidelines.
One of the biggest overhangs has been the insider selling by CEO Peter Beck’s family trust, the Equatorial Trust. Between July 6 and July 8, the trust sold about 3.28 million shares, generating proceeds of roughly $286.4 million. But the transactions were prearranged through a Rule 10b5-1 trading plan established on March 27, which permitted the sale of up to five million shares via Goldman Sachs. The plan expired on July 8, removing a repeated source of selling pressure. Beck had also voluntarily forfeited 392,155 unvested RSUs in March, underscoring that the sales were driven by diversification and estate planning, not a dim view of the business.
Should investors sell immediately? Or is it worth buying Rocket Lab?
The trust’s exits coincided with anxiety over Rocket Lab’s planned acquisition of Iridium Communications for around $8 billion, backed by a $3.6 billion bridge loan. The market has been weighing the strategic logic of a vertically integrated space platform against the dilution and integration risks that come with such a large deal. That uncertainty, combined with the insider sales, has kept a lid on the stock even as the company’s fundamentals improve.
The high level of uncertainty is also reflected in Rocket Lab’s extreme price swings. The bank of Montreal recently issued $1.376 million in equity-linked notes tied to the stock, featuring a contingent annual coupon of 20.65% — but only if the share price stays above $41.675, half the note’s starting value of $83.35. That bumper coupon is a direct measure of the stock’s annualized volatility of 94.13%, placing it among the most jumpy names in the growth-stock universe.
Wall Street’s official line remains upbeat. The consensus rating is still “Strong Buy,” with a median price target of $113.43, well above the current price. Morgan Stanley, for its part, reiterated an Overweight rating and raised its bull-case target to $293. But for the stock to reclaim those levels, the company will need to deliver on its upcoming quarterly report — set for August 6 — where analysts expect revenue of $231.79 million and a net loss of $0.07 per share. With a market capitalization of €44.36 billion, the bill for the Neutron rocket and the Iridium integration is steep, and the market is demanding proof that the operational momentum will eventually translate into shareholder returns.
Ad
Rocket Lab Stock: Buy or Sell?! New Rocket Lab Analysis from July 16 delivers the answer:
The latest Rocket Lab figures speak for themselves: Urgent action needed for Rocket Lab investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from July 16.
Rocket Lab: Buy or sell? Read more here...
